UDN Phase II Funding Opportunities: Frequently Asked Questions
Choose a RFA below for FAQs specific to that funding opportunity:
- Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-019)
- Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-018)
- Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54) (RFA-RM-17-017)
- Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-016)
- Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-015)
* Denotes FAQs added on 09/27/17
Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-019)
1) Will Clinical Site applicants be able to read the current UDN protocol?
3) Do direct costs include consortium F&A costs requested by a subcontract?
*8) Are the Applicant Information Webinar slides available online?
*10) Should the Sustainability Plan include all components or only the component being applied for?
*11) Will the single IRB be at NIH? Will there be a cost to UDN sites for the single IRB?
Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-018)
1) Will Coordinating Center applicants be able to read the current UDN protocol?
3) Do direct costs include consortium F&A costs requested by a subcontract?
*8) Are the Applicant Information Webinar slides available online?
*10) Should the Sustainability Plan include all components or only the component being applied for?
*11) Will the single IRB be at NIH? Will there be a cost to UDN sites for the single IRB?
Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54) (RFA-RM-17-017)
1) Will Model Organisms Screening Center applicants be able to read the current UDN protocol?
3) Do direct costs include consortium F&A costs requested by a subcontract?
4) Is the FY21 budget really $4350K direct costs?
8) What are the top NIH priorities for awarding a Model Organisms Screening Center?
9) How will the UDN assign gene variants to the Model Organisms Screening Center?
*17) Are the Applicant Information Webinar slides available online?
*19) Should the Sustainability Plan include all components or only the component being applied for?
*20) Will the single IRB be at NIH? Will there be a cost to UDN sites for the single IRB?
*21) How many Model Organisms Screening Centers do you anticipate will be funded?
Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-016)
1) Will Sequencing Core applicants be able to read the current UDN protocol?
3) Do direct costs include consortium F&A costs requested by a subcontract?
6) If submitting a multi-PI application, does each PD/PI need to be well-established in sequencing?
8) When does the two-week timeframe for return of raw (unassembled) sequence data start and stop?
9) Will the UDN DNA Sequencing Core need to provide DNA extraction?
10) What does re-analysis mean for previously sequenced exomes and genomes?
11) What does re-interpretation mean?
*13) Are the Applicant Information Webinar slides available online?
*15) Should the Sustainability Plan include all components or only the component being applied for?
*16) Will the single IRB be at NIH? Will there be a cost to UDN sites for the single IRB?
Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01) (RFA-RM-17-015)
1) Will Metabolomics Core applicants be able to read the current UDN protocol?
3) Do direct costs include consortium F&A costs requested by a subcontract?
8) Are letters of support from all alternate sites with special expertise necessary?
*11) Are the Applicant Information Webinar slides available online?
*13) Should the Sustainability Plan include all components or only the component being applied for?
*14) Will the single IRB be at NIH? Will there be a cost to UDN sites for the single IRB?
*15) Does the Metabolomics Core need to include a clinician in the research team?
This page last reviewed on September 27, 2017